Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFH0N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,921
Award facts
- Contract value 100% obligated
- $32,921.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $32,921.36 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs across military and veteran healthcare systems. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026.
AmerisourceBergen's prime IDC with the Defense Logistics Agency functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The contractor's federal contract portfolio demonstrates consistent capability in competitively awarded delivery orders for brand-name and generic pharmaceuticals, including diabetes medications, neurological treatments, pain management products, and other critical medical supplies. This particular delivery order for Ozempic—an injectable diabetes medication—reflects the company's role in supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles designed to meet evolving military medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26FFH0N?
SPE2DR26FFH0N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26FFH0N worth?
The government has obligated $32,921 on SPE2DR26FFH0N.
Is contract SPE2DR26FFH0N an order under another contract?
Yes. SPE2DR26FFH0N is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFH0N competed?
The extent of competition for SPE2DR26FFH0N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award